We are live on
!
Find out more
DFO
Duquesne Family Office Portfolio holdings
AUM
$3.38B
1-Year Est. Return
61.92%
This Fund
S&P 500
This Quarter
Est. Return
+21.41%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$4.07B
AUM Growth
+$1.01B
(+33%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
8.33%
Top 10 Holdings %
Top 10 Hldgs %
50.54%
Holding
87
New
35
Increased
13
Reduced
18
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entegris
ENTG
|
+$125M |
| 2 |
Microsoft
MSFT
|
+$87.3M |
| 3 |
Insmed
INSM
|
+$67.6M |
| 4 |
Warner Bros
WBD
|
+$61M |
| 5 |
Restaurant Brands International
QSR
|
+$50.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$133M |
| 2 |
Coherent
COHR
|
+$76.6M |
| 3 |
Woodward
WWD
|
+$50.9M |
| 4 |
Philip Morris
PM
|
+$49.7M |
| 5 |
Natera
NTRA
|
+$49.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.61% |
| 2 | Technology | 20.5% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 10.55% |
| 5 | Financials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHYM
51
Chime Financial
CHYM
$11.2B
| $16.1M | 0.4% |
+466,825
| New | +$15.4M |
|
52
Banco Macro
BMA
$5.34B
| $15.5M | 0.38% |
220,900
-210,915
| -49% | -$17.4M |
|
53
NewAmsterdam Pharma
NAMS
$3.32B
| $15.1M | 0.37% |
832,175
+31,815
| +4% | +$580K |
|
54
Viking Therapeutics
VKTX
$3.96B
| $14.6M | 0.36% |
+549,295
| New | +$14.5M |
|
55
Galicia Financial Group
GGAL
$7.35B
| $11.7M | 0.29% |
231,481
-150,000
| -39% | -$8.59M |
|
56
BWX Technologies
BWXT
$15.6B
| $11M | 0.27% |
+76,475
| New | +$8.93M |
|
|
57
CALL
Insmed
INSM
$28.3B
| $10.1M | 0.25% |
+100,000
| New | +$7.65M |
|
58
BBB Foods
TBBB
$4.92B
| $10M | 0.25% |
+360,550
| New | +$10.1M |
|
59
D.R. Horton
DHI
$42.1B
| $9.98M | 0.25% |
+77,400
| New | +$9.53M |
|
60
Lennar Class A
LEN
$21.2B
| $9.94M | 0.24% |
+89,900
| New | +$9.74M |
|
61
Builders FirstSource
BLDR
$8.12B
| $9.93M | 0.24% |
+85,065
| New | +$9.82M |
|
62
Freeport-McMoran
FCX
$97.2B
| $9.74M | 0.24% |
224,800
-793,305
| -78% | -$30.1M |
|
|
CCC
63
CCC Intelligent Solutions
CCC
$4.02B
| $9.48M | 0.23% |
1,007,944
-4,587,095
| -82% | -$41M |
|
64
Enliven Therapeutics
ELVN
$4.43B
| $9.29M | 0.23% |
+463,000
| New | +$8.77M |
|
65
Elbit Systems
ESLT
$40.1B
| $8.22M | 0.2% |
+18,287
| New | +$7.42M |
|
66
Thermo Fisher Scientific
TMO
$217B
| $4.95M | 0.12% |
+12,200
| New | +$5.1M |
|
67
Danaher
DHR
$143B
| $4.88M | 0.12% |
+24,700
| New | +$4.79M |
|
68
Chemours
CC
$2.42B
| $4.83M | 0.12% |
+421,800
| New | +$4.75M |
|
69
Joby Aviation
JOBY
$8.52B
| $332K | 0.01% |
31,489
| – | – |
|
70
American Airlines Group
AAL
$10.6B
| – | – |
-133,728
| Closed | -$1.41M |
|
71
Amazon
AMZN
$2.97T
| – | – |
-136,765
| Closed | -$26M |
|
72
Antero Resources
AR
$10.8B
| – | – |
-258,400
| Closed | -$10.4M |
|
73
Ascendis Pharma A/S
ASND
$16.7B
| – | – |
-158,720
| Closed | -$24.7M |
|
74
BridgeBio Pharma
BBIO
$16.3B
| – | – |
-438,050
| Closed | -$15.1M |
|
75
Brookfield
BN
$108B
| – | – |
-473,888
| Closed | -$16.6M |
|
Similar funds
VFCM
OAM
EFM
BG
DIA
5NCM
MCM
QCG
Duquesne Family Office's Q2 2025 Portfolio in Review
As of Q2 2025, Duquesne Family Office held 87 positions worth $4.07B, up 33% from $3.06B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Duquesne Family Office deployed $339M of net new capital in Q2 2025, opening 35 new positions and adding to 13 existing holdings. Its largest new stake was Entegris: 1,645,885 shares worth $133M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Coupang, an estimated $133M trimmed.
- Duquesne Family Office's largest Q2 2025 buy was Entegris: 1,645,885 shares worth $133M.
- Duquesne Family Office added most to Insmed in Q2 2025, an estimated $67.6M increase.
- Duquesne Family Office's biggest Q2 2025 reduction was Coupang, cutting an estimated $133M.
- Duquesne Family Office fully exited Capital One in Q2 2025, selling an estimated $35.4M.
- Duquesne Family Office's ten largest holdings make up 51% of its $4.07B portfolio in Q2 2025.
- Duquesne Family Office opened 35 new positions and closed 18 in Q2 2025.
- Duquesne Family Office's portfolio value rose 33% quarter-over-quarter to $4.07B.
Based on Duquesne Family Office's 13F filing for Q2 2025, filed 15 Aug 2025.